0001209191-19-023200.txt : 20190403 0001209191-19-023200.hdr.sgml : 20190403 20190403164352 ACCESSION NUMBER: 0001209191-19-023200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rakhit Amit CENTRAL INDEX KEY: 0001704636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 19729596 MAIL ADDRESS: STREET 1: C/O OVID THERAPEUTICS INC. STREET 2: 1460 BROADWAY, SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-01 0 0001636651 Ovid Therapeutics Inc. OVID 0001704636 Rakhit Amit C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 0 1 0 0 CMO and PMO Employee Stock Option (Right to Buy) 1.76 2019-04-01 4 A 0 50000 0.00 A 2029-03-31 Common Stock 50000 50000 D 25% of the shares subject to the Stock Option will vest and become exercisable on April 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. /s/Danielle Mann for Amit Rakhit by POA 2019-04-03